MENU
+Compare
AVNS
Stock ticker: NYSE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$11.89
Change
+$0.49 (+4.30%)
Capitalization
529.18M

AVNS Avanos Medical Forecast, Technical & Fundamental Analysis

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally... Show more

AVNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AVNS with price predictions
Jan 13, 2026

AVNS in upward trend: 10-day moving average moved above 50-day moving average on January 08, 2026

The 10-day moving average for AVNS crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on AVNS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AVNS just turned positive on January 07, 2026. Looking at past instances where AVNS's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNS advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 142 cases where AVNS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AVNS moved out of overbought territory on January 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where AVNS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

AVNS moved below its 50-day moving average on January 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVNS broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.680) is normal, around the industry mean (62.991). P/E Ratio (33.106) is within average values for comparable stocks, (38.209). AVNS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.662). AVNS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.753) is also within normal values, averaging (39.712).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
AVNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVNS is expected to report earnings to rise 13.64% to 25 cents per share on February 24

Avanos Medical AVNS Stock Earnings Reports
Q4'25
Est.
$0.25
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.03
The last earnings report on November 05 showed earnings per share of 21 cents, beating the estimate of 18 cents. With 139.53K shares outstanding, the current market capitalization sits at 529.18M.
A.I. Advisor
published General Information

General Information

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5405 Windward Parkway
Phone
+1 844 428-2667
Employees
3771
Web
https://www.avanos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREJX27.070.21
+0.78%
Principal Real Estate Securities J
FERCX57.17N/A
N/A
Fidelity Advisor Emerging Asia C
SIEMX14.82-0.03
-0.20%
SEI Emerging Markets Equity F (SIT)
TLAFX11.37-0.05
-0.44%
Transamerica Large Core ESG R4
PDFDX56.93-0.39
-0.68%
Perkins Discovery

AVNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with ENOV. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-4.76%
ENOV - AVNS
52%
Loosely correlated
-8.50%
STE - AVNS
49%
Loosely correlated
-0.35%
SYK - AVNS
48%
Loosely correlated
-1.54%
IART - AVNS
47%
Loosely correlated
-6.16%
ZBH - AVNS
46%
Loosely correlated
-3.40%
More

Groups containing AVNS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-4.76%
Health Services
category (412 stocks)
2%
Poorly correlated
-0.23%
Medical/Nursing Services
category (220 stocks)
-2%
Poorly correlated
-0.32%